CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
Sign Up to like & getrecommendations! Published in 2021 at "Molecular Metabolism"
DOI: 10.1016/j.molmet.2021.101428
Abstract: Objective Enhanced de novo lipogenesis (DNL) in hepatocytes is a major contributor to nonalcoholic fatty liver disease (NAFLD). Fatty acid translocase (FAT/CD36) is involved in the pathogenesis of NAFLD through facilitating free fatty acids uptake.… read more here.
Keywords: srebp1 processing; novo lipogenesis; cd36; cd36lko mice ... See more keywords